AC
ENTL

Aisling Capital’s Entellus Medical, Inc. Common Stock ENTL Stock Holding History

Aisling Capital’s Portfolio ENTL Stock Details ENTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-528,655
Closed -$12.9M – 12
2017
Q4 		$12.9M Hold
528,655
– – 2.55% 5
2017
Q3 		$9.76M Buy
+528,655
New +$9.16M 1.6% 7

Aisling Capital's ENTL Position: Q1 2018 in Review

Aisling Capital sold out of Entellus Medical, Inc. Common Stock (ENTL) in Q1 2018, closing a stake of 528,655 shares — an estimated $12.9M sold.

Aisling Capital first reported a position in ENTL in Q3 2017 and held it in 2 quarters. The position peaked at $12.9M in Q4 2017. 0 funds tracked by Wall St. Rank hold ENTL as of Q1 2018.

  • Aisling Capital reported no remaining Entellus Medical, Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Aisling Capital sold 528,655 Entellus Medical, Inc. Common Stock shares in Q1 2018, an estimated $12.9M.
  • Aisling Capital first reported a position in Entellus Medical, Inc. Common Stock in Q3 2017 and held it in 2 quarters.
  • Aisling Capital's Entellus Medical, Inc. Common Stock position peaked at $12.9M in Q4 2017.
  • 0 funds tracked by Wall St. Rank held Entellus Medical, Inc. Common Stock as of Q1 2018.

Based on Aisling Capital's 13F filing for Q1 2018, filed 14 May 2018.